Boks Dominique E S, Trujillo Aliana P, Voogd Adri C, Morreau Hans, Kenter Gemma G, Vasen Hans F A
Netherlands Foundation for the Detection of Hereditary Tumors, Leiden University Medical Center, Poortgebouw Zuid, 2333 AA Leiden, Netherlands.
Int J Cancer. 2002 Nov 10;102(2):198-200. doi: 10.1002/ijc.10667.
Endometrial carcinoma (EC) is the most common extracolonic tumor associated with hereditary nonpolyposis colorectal cancer (HNPCC). HNPCC increases the risk of EC compared to the general population. Patients with HNPCC have a better prognosis than patients with common sporadic colorectal cancer. It is unknown, however, whether the survival rate of HNPCC-associated EC is higher than that of sporadic EC. The aim of our study was to compare the survival rates of HNPCC-associated EC with sporadic EC. From the registry of the Netherlands Foundation for Hereditary Tumors, 50 patients with HNPCC-associated EC from 46 families harboring a germline mutation or fulfilling the Amsterdam Criteria II were age- and stage-matched with 100 patients with sporadic EC registered in the Eindhoven Cancer Registry in the Netherlands. Survival rates were analyzed. The overall 5-year cumulative survival rates for patients with HNPCC-associated EC was 88% and 82% for patients with sporadic EC (p = 0.59). In Stages IA, IB and IC, the survival rates of patients with HNPCC-associated EC and sporadic EC were 92% and 91%, respectively (p = 0.90). In Stages IIIA and IIIC, the survival rates for HNPCC-associated EC and sporadic EC were 72% and 50%, respectively (p = 0.38). Furthermore, there was no significant difference in the distribution of tumor histologic subtypes in the study and control groups (p = 0.55). The outcomes in survival in EC in the general population and in women from families with HNPCC do not differ significantly. These results may have important implications in our understanding of EC and the role of early screening.
子宫内膜癌（EC）是与遗传性非息肉病性结直肠癌（HNPCC）相关的最常见的结肠外肿瘤。与普通人群相比，HNPCC增加了患EC的风险。HNPCC患者的预后比常见散发性结直肠癌患者更好。然而，HNPCC相关的EC的生存率是否高于散发性EC尚不清楚。我们研究的目的是比较HNPCC相关的EC与散发性EC的生存率。从荷兰遗传性肿瘤基金会的登记处，选取了46个携带种系突变或符合阿姆斯特丹标准II的家庭中的50例HNPCC相关的EC患者，与荷兰埃因霍温癌症登记处登记的100例散发性EC患者进行年龄和分期匹配。分析生存率。HNPCC相关的EC患者的总体5年累积生存率为88%，散发性EC患者为82%（p = 0.59）。在IA期、IB期和IC期，HNPCC相关的EC患者和散发性EC患者的生存率分别为92%和91%（p = 0.90）。在IIIA期和IIIC期，HNPCC相关的EC和散发性EC的生存率分别为72%和50%（p = 0.38）。此外，研究组和对照组肿瘤组织学亚型的分布没有显著差异（p = 0.55）。普通人群中EC的生存率与HNPCC家族中女性的生存率没有显著差异。这些结果可能对我们理解EC和早期筛查的作用具有重要意义。
